載入...
Loss of S100 antigenicity in metastatic melanoma
Melanoma is a highly malignant disease that may initially present as a poorly differentiated metastatic tumor. Therefore, the S100 immunostain, immunoreactive in 96% to 99% of melanoma, is used to evaluate poorly differentiated malignant tumors. To develop criteria for correctly diagnosing S100-nega...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2005
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2656365/ https://ncbi.nlm.nih.gov/pubmed/16153466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2005.07.010 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|